Linlin Ma1, Bo Hyun Lee1, Rongrong Mao1, Anping Cai1, Yunfang Jia1, Heather Clifton1, Saul Schaefer1, Lin Xu1, Jie Zheng2. 1. From the Department of Physiology and Membrane Biology (L.M., B.H.L., J.Z.) and Division of Cardiovascular Medicine (H.C., S.S.), University of California School of Medicine, Davis; Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, Yunnan Province, China (R.M, A.C., Y.J., L.X.); and Institute for Molecular Bioscience, University of Queensland, St Lucia, Queensland, Australia (L.M.). 2. From the Department of Physiology and Membrane Biology (L.M., B.H.L., J.Z.) and Division of Cardiovascular Medicine (H.C., S.S.), University of California School of Medicine, Davis; Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, Yunnan Province, China (R.M, A.C., Y.J., L.X.); and Institute for Molecular Bioscience, University of Queensland, St Lucia, Queensland, Australia (L.M.). jzheng@ucdavis.edu.
Abstract
OBJECTIVE: Nicotinic acid (also known as niacin or vitamin B3), widely used to treat dyslipidemias, represents an effective and safe means to reduce the risk of mortality from cardiovascular disease. Nonetheless, a substantial fraction of patients discontinue treatment because of a strong side effect of cutaneous vasodilation, commonly termed flushing. In the present study, we tested the hypothesis that nicotinic acid causes flushing partially by activating the capsaicin receptor TRPV1, a polymodal cellular sensor that mediates the flushing response on consumption of spicy food. APPROACH AND RESULTS: We observed that the nicotinic acid-induced increase in blood flow was substantially reduced in Trpv1(-/-) knockout mice, indicating involvement of the channel in flushing response. Using exogenously expressed TRPV1, we confirmed that nicotinic acid at submillimolar to millimolar concentrations directly and potently activates TRPV1 from the intracellular side. Binding of nicotinic acid to TRPV1 lowers its activation threshold for heat, causing channel opening at physiological temperatures. The activation of TRPV1 by voltage or ligands (capsaicin and 2-aminoethoxydiphenyl borate) is also potentiated by nicotinic acid. We further demonstrated that nicotinic acid does not compete directly with capsaicin but may activate TRPV1 through the 2-aminoethoxydiphenyl borate activation pathway. Using live-cell fluorescence imaging, we observed that nicotinic acid can quickly enter the cell through a transporter-mediated pathway to activate TRPV1. CONCLUSIONS: Direct activation of TRPV1 by nicotinic acid may lead to cutaneous vasodilation that contributes to flushing, suggesting a potential novel pathway to inhibit flushing and to improve compliance.
OBJECTIVE:Nicotinic acid (also known as niacin or vitamin B3), widely used to treat dyslipidemias, represents an effective and safe means to reduce the risk of mortality from cardiovascular disease. Nonetheless, a substantial fraction of patients discontinue treatment because of a strong side effect of cutaneous vasodilation, commonly termed flushing. In the present study, we tested the hypothesis that nicotinic acid causes flushing partially by activating the capsaicin receptorTRPV1, a polymodal cellular sensor that mediates the flushing response on consumption of spicy food. APPROACH AND RESULTS: We observed that the nicotinic acid-induced increase in blood flow was substantially reduced in Trpv1(-/-) knockout mice, indicating involvement of the channel in flushing response. Using exogenously expressed TRPV1, we confirmed that nicotinic acid at submillimolar to millimolar concentrations directly and potently activates TRPV1 from the intracellular side. Binding of nicotinic acid to TRPV1 lowers its activation threshold for heat, causing channel opening at physiological temperatures. The activation of TRPV1 by voltage or ligands (capsaicin and 2-aminoethoxydiphenyl borate) is also potentiated by nicotinic acid. We further demonstrated that nicotinic acid does not compete directly with capsaicin but may activate TRPV1 through the 2-aminoethoxydiphenyl borate activation pathway. Using live-cell fluorescence imaging, we observed that nicotinic acid can quickly enter the cell through a transporter-mediated pathway to activate TRPV1. CONCLUSIONS: Direct activation of TRPV1 by nicotinic acid may lead to cutaneous vasodilation that contributes to flushing, suggesting a potential novel pathway to inhibit flushing and to improve compliance.
Authors: Andras Garami; Eszter Pakai; Daniela L Oliveira; Alexandre A Steiner; Samuel P Wanner; M Camila Almeida; Vladimir A Lesnikov; Narender R Gavva; Andrej A Romanovsky Journal: J Neurosci Date: 2011-02-02 Impact factor: 6.167
Authors: M Tominaga; M J Caterina; A B Malmberg; T A Rosen; H Gilbert; K Skinner; B E Raumann; A I Basbaum; D Julius Journal: Neuron Date: 1998-09 Impact factor: 17.173
Authors: James McKenney; Harold Bays; Michael Koren; Christie M Ballantyne; John F Paolini; Yale Mitchel; Abigaile Betteridge; Olga Kuznetsova; Aditi Sapre; Christine McCrary Sisk; Darbie Maccubbin Journal: J Clin Lipidol Date: 2010-02-12 Impact factor: 4.766
Authors: Narender R Gavva; Lana Klionsky; Yusheng Qu; Licheng Shi; Rami Tamir; Steve Edenson; T J Zhang; Vellarkad N Viswanadhan; Attila Toth; Larry V Pearce; Todd W Vanderah; Frank Porreca; Peter M Blumberg; Jack Lile; Yax Sun; Ken Wild; Jean-Claude Louis; James J S Treanor Journal: J Biol Chem Date: 2004-03-02 Impact factor: 5.157
Authors: Sorin Tunaru; Jukka Kero; Annette Schaub; Christian Wufka; Andree Blaukat; Klaus Pfeffer; Stefan Offermanns Journal: Nat Med Date: 2003-02-03 Impact factor: 53.440
Authors: Richard L Dunbar; Harsh Goel; Sony Tuteja; Wen-Liang Song; Grace Nathanson; Zeeshan Babar; Dusanka Lalic; Joel M Gelfand; Daniel J Rader; Gary L Grove Journal: J Lipid Res Date: 2017-01-23 Impact factor: 5.922
Authors: Awani Upadhyay; Aditya Pisupati; Timothy Jegla; Matt Crook; Keith J Mickolajczyk; Matthew Shorey; Laura E Rohan; Katherine A Billings; Melissa M Rolls; William O Hancock; Wendy Hanna-Rose Journal: Nat Commun Date: 2016-10-12 Impact factor: 14.919
Authors: Arnold Markovics; Kinga Fanni Tóth; Katalin Eszter Sós; József Magi; Adrienn Gyöngyösi; Zoltán Benyó; Christos C Zouboulis; Tamás Bíró; Attila Oláh Journal: J Cell Mol Med Date: 2019-07-05 Impact factor: 5.310